C. Akdag Et Al. , "Dry powders for the inhalation of ciprofloxacin or levofloxacin combined with a mucolytic agent for cystic fibrosis patients.," Drug development and industrial pharmacy , vol.43, pp.1378-1389, 2017
Akdag, C. Et Al. 2017. Dry powders for the inhalation of ciprofloxacin or levofloxacin combined with a mucolytic agent for cystic fibrosis patients.. Drug development and industrial pharmacy , vol.43 , 1378-1389.
Akdag, C., SAHIN, S., BUTTINI, F., BALDUCCI, A., MONTANARI, S., VURAL, I., ... ONER, L.(2017). Dry powders for the inhalation of ciprofloxacin or levofloxacin combined with a mucolytic agent for cystic fibrosis patients.. Drug development and industrial pharmacy , vol.43, 1378-1389.
Akdag, YAĞMUR Et Al. "Dry powders for the inhalation of ciprofloxacin or levofloxacin combined with a mucolytic agent for cystic fibrosis patients.," Drug development and industrial pharmacy , vol.43, 1378-1389, 2017
Akdag, YAĞMUR A. Et Al. "Dry powders for the inhalation of ciprofloxacin or levofloxacin combined with a mucolytic agent for cystic fibrosis patients.." Drug development and industrial pharmacy , vol.43, pp.1378-1389, 2017
Akdag, C. Et Al. (2017) . "Dry powders for the inhalation of ciprofloxacin or levofloxacin combined with a mucolytic agent for cystic fibrosis patients.." Drug development and industrial pharmacy , vol.43, pp.1378-1389.
@article{article, author={YAĞMUR AKDAĞ ÇAYLI Et Al. }, title={Dry powders for the inhalation of ciprofloxacin or levofloxacin combined with a mucolytic agent for cystic fibrosis patients.}, journal={Drug development and industrial pharmacy}, year=2017, pages={1378-1389} }